Corpus Intelligence IC Memo — SSH -NE OHIO 2026-04-26 12:27 UTC
IC Memo — SSH -NE OHIO
Investment Committee Memorandum | OH | 30 beds | Grade D | EBITDA uplift $782K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH -NE OHIO

CCN 362016 | STARK, OH | 30 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SSH -NE OHIO is a 30-bed suburban community hospital in STARK, OH with $10.6M in net patient revenue and a 1.3% operating margin. The hospital serves a payer mix of 33.6% Medicare, 8.7% Medicaid, and 57.7% commercial.

Thesis: Turnaround. Our ML models identify $782K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.3% to 8.7% (+741bps).

Net Revenue HCRIS$10.6M
Current EBITDA COMPUTED$136K
Operating Margin COMPUTED1.3%
Occupancy HCRIS44.8%
Revenue / Bed COMPUTED$352K
Net-to-Gross HCRIS15.5%
Distress Probability ML50.1%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
96
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 1.3% places it above the state median. Among 96 size-comparable peers (15-60 beds), the median margin is -1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (15-60), prioritizing same-state peers. 96 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH -NE OHIO (Target)OH30$10.6M1.3%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
AVITA ONTARIO HOSPITALOH49$109.2M16.0%
MERCY HEALTH-TIFFIN HOSPITAL OH35$103.0M18.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $782K (741bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$222K+210bp18mo
Denial Rate Reduction12.0%6.5%$211K+200bp12mo
Cost to Collect4.5%2.5%$211K+200bp12mo
A/R Days Reduction5200.0%3800.0%$128K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$222K
Denial Rate Reduction
$211K
Cost to Collect
$211K
A/R Days Reduction
$128K
Clean Claim Rate
$10K
Total EBITDA Uplift$782K
Current EBITDA$136K
+ RCM Uplift+$782K
Pro Forma EBITDA$918K
Current Margin1.3%
Pro Forma Margin8.7%
WC Released (1x)$405K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$210K$8.7M41.58x110.8%
Base (11x exit)10.0x11.0x$210K$9.7M46.06x115.1%
Bull Case9.0x11.0x$189K$12.3M65.21x130.6%
Bull (12x exit)9.0x12.0x$189K$13.5M71.44x134.8%
Bear Case11.0x10.0x$231K$4.7M20.55x83.0%
Bear (11x exit)11.0x11.0x$231K$5.3M22.93x87.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 96 hospitals with 15-60 beds
  • Same-state prioritization (n=97)
  • Comp margins: P25=-11.1% / P50=-1.7% / P75=12.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.